English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52364858    ???header.onlineuser??? :  946
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"ou d l"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 76-85 of 103  (11 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-04-10T12:51:02Z Simultaneous visualization of the subfemtomolar expression of microRNA and microRNA target gene using HILO microscopy Chang P.-L.; Lin W.-Y.; Chiun Hsu; Chang H.-Y.; Ou D.-L.; Lin Y.-Z.; Lin Y.-Z.;Ou D.-L.;Chang H.-Y.;Lin W.-Y.;Chiun Hsu;Chang P.-L.
臺大學術典藏 2020-04-10T12:51:01Z Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy Lin Y.-Y.;Tan C.-T.;Chen C.-W.;Ou D.-L.;Cheng A.-L.;Chiun Hsu; Lin Y.-Y.; Tan C.-T.; Chen C.-W.; Ou D.-L.; Cheng A.-L.; Chiun Hsu
臺大學術典藏 2020-04-10T12:51:01Z Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy Shao Y.-Y.;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Chiun Hsu; Shao Y.-Y.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Chiun Hsu
臺大學術典藏 2020-04-10T12:51:00Z Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma Ou D.-L.;Lin Y.-Y.;Hsu C.-L.;Lin Y.-Y.;Chen C.-W.;Yu J.-S.;Miaw S.-C.;Hsu P.-N.;Cheng A.-L.;Chiun Hsu; Ou D.-L.; Lin Y.-Y.; Hsu C.-L.; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; Hsu P.-N.; Cheng A.-L.; Chiun Hsu
臺大學術典藏 2020-04-10T12:16:01Z Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression Hsu C.; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; YU-YUN SHAO; Cheng A.-L.; Ou D.-L.
臺大學術典藏 2020-04-10T12:15:58Z Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy Yu-Yun Shao;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Hsu C.; YU-YUN SHAO; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C.
臺大學術典藏 2020-04-09T09:39:09Z Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy Shao, Y. Y.; Chen, B. B.; Ou, D. L.; Lin, Z. Z.; Hsu, C. H.; Wang, M. J.; Cheng, A. L.; Hsu, C.
臺大學術典藏 2020-03-07T06:56:33Z KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-06T08:25:06Z Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma Ou D.-L.;Chang C.-J.;Yung-Ming Jeng;Lin Y.-J.;Lin Z.-Z.;Gandhi A.K.;Liao S.-C.;Huang Z.-M.;Hsu C.;Cheng A.-L.; Ou D.-L.; Chang C.-J.; YUNG-MING JENG; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; Cheng A.-L.
臺大學術典藏 2020-03-05T12:22:25Z KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells Liau J.-Y.; SHAN-CHI YU; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.

Showing items 76-85 of 103  (11 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page